Angiosperms, dicots
Explanation:
Angiosperms are highly differentiated vascular plants which can produce flowers and bear fruits with seeds in them. These flowering plants undergo reproduction and produces new plants. The reproductive parts like ovules and ovaries, stigma, stamen, pollen are all present in the flowers.
Angiosperms can either be a monocot or dicot. If they contain two embryonic leaves or cotyledons they are referred as dicots. Flowering angiosperms like geranium, magnolias are all dicots.
Geranium is a dicot angiosperms that produces small purple flowers.
Gymnosperms or bryophytes do not bear flowers or fruits. Monocots have only embryonic leaf.
It's called the fruiting body.
Autosomal dominant condition occurs when alleles of genes present on chromosomes in the autosomes (somatic) mask the effect of the other allele.
They can produce a light brown kid and the chances of producing this is 50%.
- Light brown color is dominant to black. A light brown male is mated to a black female, producing a black kid.
- For the two to produce a black kid which is in the recessive condition, the male has to be heterozygous for the condition (Bb).
Let light brown be (BB or Bb) and black be (bb)
Parents : B b x b b
Offspring genotype: Bb bb
Ratio: 1 : 1 (50%)
Learn more about autosomal dominance: brainly.com/question/7135379
Answer:
The answer is B
Explanation:
The definition of a light year is the unit of astronomical distance, though it is called a light year it is actually a measurement of distance, so the answer, "the time it takes light to travel 1 million km is the correct answer.
Answer:
An evaluation of the impact of immunoenzymatic assays on immunochemical-based analytics in the last 4 decades, in the detection of infectious agents or products associated with their presence and (or) pathogenic activity was made. In addition, there is an incursion into some designs and formats that these immunoassays have had since electrochemical detection methods, tests to detect proteolytic activity of microbial origin and its inhibitors as possible therapeutic targets, direct triple antibody immunoassays to achieve greater sensitivity, alternative developers of enzymatic activity, trials for the study of viral serology with a minimum of determinations, as well as proficiency tests to evaluate the efficacy of controlled vaccine candidates in selected peptide combinations. It was concluded with a quick vision of the immediate future of this type of immunoassays in the light of emerging analytical detection technologies.